The examination of the usefulness of anti-Sm antibody mesuremant with SmD peptide.

The examination of the usefulness of anti-Sm antibody mesuremant with SmD peptide. - The examinatin of the usefulness of anti-Sm antibody mesuremant with SmD peptide.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012844

Enrollment

225

Registered

2014-01-14

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus,Mixed connective tissue disease,Sjogren&#39

Interventions

obtain a blood sample

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To meet following criteria. SLE classification criteria, SS diagnostic criteria, SSc diagnostic criteria, PM/DM diagnostic criteria, RA classification criteria.

Exclusion criteria

Exclusion criteria: Patient diagnosed with overlap syndrome

Design outcomes

Primary

Measure	Time frame
Correlatitivity and concordance rate between Elia SmDp and Elia Sm, Clinical sensitivity,specificity and ROC analysis of Elia SmDp and Elia SmD, Antibody titer of Elia SmDp and Elia SmD for control disease, Conformation test in discordant samples between Elia SmDp and Elia SmD	—

Countries

Japan

Contacts

Public ContactMasakazu matsushita

Juntendo University, Sclool of Medicine Depertment of internal medicine and rheumatology

collagen@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026